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Abstract
Teratology, study of abnormal prenatal development, as a descriptive
science has starts with written language. The modern experimental
teratology era started in the early quarter of 20th centaury. Since the
thalidomide catastrophe in early 1960s regulatory agencies launched
requirements for new drugs to be thoroughly tested on animals prior
to human use. One of the major concerns in the teratological studies
is the mechanism of teratogenesis; it is very difficult to know the
exact mechanism of teratogenesis. However there are many proposed
mechanism of  teratogenesis  by  Wilson  1973.  Teratogens  induce  one
or multiple unique pathogenic responses in the developing embryos.
Susceptibility f teratogenesis varies with age and therefore can be
divided into three developmental periods: early embryonic
development, organogenesis and early differentiation, and late
embryonic development.
Animal based studies provide the initial guideline if a chemical or
drug may present a teratogenic risk. A variety of laboratory animals
from different classes of animals are being used for the teratological
studies. Rat, rabbit, mice, hamster, and non human primates are the
most prevalent laboratory animal species of the mammal class.
Xenopus laevis of the amphibian class has been used and suggested as
a model for mammalian teratogenicity. From the bird class chicken,
duck and quail have been used most often in laboratory studies.
Zebrafish, Japanese medaka and fathead minnow are the most
commonly used laboratory fish species, promoted by OECD for
future testing of chemical toxicity. Teratogens can be classified as
recreational and social teratogens, pharmaceutical teratogens,
industrial and environmental teratogens, agricultural teratogens, and
metabolic and infectious diseases. In the present study model
substances were selected from the different classes of teratogens. The
selected substances were; retinoic acid, lithium, ethanol, 6-
aminonicotinamide, ochratoxin A and arsenic,
   .
Key words:  teratology; teratogenesis; retinoic acid; lithium; ethanol;
6-aminonicotinamide; ochratoxin A ; arsenic; zebrafish
 12
Background
Historical background of teratology
Teratology is the study of abnormal prenatal development and congenital
malformations, which may be caused by exposure to chemicals or physical
factors. Teratology as a descriptive science  starts with written language, a marble
sculpture from southern Turkey dating back to 6500 B.C., depicts conjoined twins
(Warknay,1983), and Egyptian wall paintings of human malformed conditions
such as cleft palate and achondroplasia have been dated as early as 5000 years
ago. The Babylonians Greek and Romans believed that abnormal infants were
reflections of stellar events and such were considered to be portents of future. The
Latin word monstrum from monstrare (to show) or monere (to warn) is derived
from this perceived ability of malformed infants to foretell the future. In turn root
of teratogenesis is from Greek word teraton meaning “wonder” and by derivation
“monster” (Francis, 1994).
Modern experimental teratology as a science was born in 1920s and 1930s, when
the birth of malformed piglets from sows fed an experimental diet high in fat or
deficient in vitamin A elicited shocking teratogenic effects (Hale, 1933;
Schardein 1993). Subsequent evidence about teratology came to light over the
next two decades; correlation of particular birth defects of children with maternal
Rubella infection in 1941 (Gregg, 1941) and with environmental mercury
contamination in 1956 (Igata, 1993); malformed rat born following the inclusion
of a growth inhibiting amino acid mimic in their mother’s diet (Murphy et al.,
1956) and malformed children born following failed Aminoptern induced
abortions (Thiersh, 1956).
Thalidomide represents the 1st case of a substance producing minimal toxicity in
the adult but considerable toxicity in the foetus (MC Bride, 1961; Lenz, 1966).
Since the Thalidomide catastrophe regulatory agencies launched requirements for
new drugs to be thoroughly tested on animals prior to approval for marketing
(Bailey et. al., 2005; Rowan, 1984).
The confounding nature of results from experiences based on animal studies has
required principles to be elaborated and revised (Wilson, 1997; Finnell, 1999).
Many variables have been found to interfere with interspecies and animal human
comparisons (Nielsen et al., 2001; Palmer, 1986), these must be considered when
designing developmental and reproductive toxicology studies. They can be
summarized as;
I. Susceptibility to teratogenesis depends on the genotype of the conceptus
and how it interacts with the environment (Schardein, 1993).
II. Susceptibility to a teratogenic agent varies with the developmental stage at
which the exposure occurs (Wilson, 1972).
III. Teratogenic agents act in specific ways on developing cells and tissues to
initiate abnormal embryogenesis (Wilson, 1973).
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IV. Access of an adverse environmental agent to developing tissues depends on
the nature of the agent (Polifka and Friedman, 1999).
V. The manifestations of deviant development increase in degree as dosage
increase from the co-effect to the lethal level (Brent, 1995).
VI. Manifestation of deviant development includes death, malformation and
growth retardation. (Wilson ,1972).
Animal based studies of developmental toxicology provide the initial
information’s on whether a drug or chemical constitute a teratogenic risk
substance. Typically, a range of doses administered via the most appropriate route
is given to pregnant animals during the period of embryonic organogenesis and
the outcomes are compared to untreated control animals. The most prevalent
species used are mice, rats, hamster, primates and rabbits but no one species is an
ideal experimental animal because they are not fulfilling the “Ideal” criteria such
as producing large litters after a short gestation, inexpensive maintenance and an
inability and unwillingness to’ bite,  scratch , kick, howl or squeal’ (Wilson,
1975). It is also acknowledged that the laboratory handling of animals can induce
physiological stress responses and cause alterations in behaviour and both these
factors can affect teratogenicity results. Participation in the teratology research
itself is so inherently stressful that this can never be excluded (Balcombe et al.,
2004).
During the past 30-40 years a lot of money has been spent on teratological testing,
but still scientist are looking for alternative laboratory species which can produce
large litter after a short gestation, easy and inexpensive handling, inability and
unwillingness to’ bite, kick, scratch , howl or squeal’ (Wilson, 1975).
Mechanism of Teratogenesis
Mechanism of teratogenesis falls into two broad categories based on the etiology
of the congenital malformation:
a. Errors in the genetic programming based on deviations in the
genotype of the embryo or the low probability for errors of a normal
genotype.
b. Environmental agents or factors that interact with the embryo
during the period of development, e.g., drugs, chemicals, radiation,
infections or mechanical factors.
Etiology of malformations includes both genetic and environmental factors, but
there is another large category labelled as unknown, e.g., polygenic,
multifactorial, spontaneous errors of development and synergistic interactions of
teratogens.
To induce malformations, teratogens must cross the placenta or reach the
developing embryo through some other route, which makes phenomenon of
teratogenesis applicable to all organisms including those in which embryonic
development occurs outside the mother.
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A number of suggested mechanisms involved in teratogenesis has been proposed
by Wilson (1973);
1. Mutation:  Changes in the nucleotide sequence in DNA. However,
mutation is unlikely to play a role in the production of malformations
following in utero exposure. Mutagens usually produce cytotoxic effects
which are related to the cell destruction not to the genetic changes that
persist and effect embryonic development for many cell cycles in the
developing embryo.
2. Chromosomal aberrations: alterations in the amount of DNA. However,
chromosomal aberrations play little or no role when induced in somatic
cells of the developing embryo but may cause cell death and retardation
of differentiation.
3. Altered nucleic acid synthesis and function: a disturbance in translation,
transcription or DNA synthesis.
4. Mitotic interference: a disturbance in the cell cycle.
5. Lack of precursors, substrates and co-enzymes for biosynthesis: a general
or specific nutritional deficiency.
6. Altered energy source: interference with the citric acid cycle or terminal
electron transport system.
7. Enzyme inhibition: limited or specific enzyme inhibition.
8. Osmolar imbalance: alterations in the fluid pressures, viscosities and
osmotic pressures.
9. Altered membrane characteristics: a disruption in membrane transport
and permeability.
10. Other mechanisms: an extensive list of possible mechanisms for which
there is a little scientific support.
In the developing embryo many of the above mentioned cellular insults can cause
unique pathogenic responses (Tyl, 2000) such as:
1. Reduced cell proliferation.
2. Cell death.
3. Altered cell-cell interactions
4. Reduced biosynthesis.
5. Mechanical disruption of developing structures.
6. Inhibitions of morphogenetic movements.
Susceptibility of teratogenesis with age
Susceptibility to teratogenesis varies with the developmental stage (F1) (Tyl,
2000). It is generally accepted that every teratogen acts at specific times of
development, and that these vary, within limits, between agents. The limits are
determined by the developmental sequences of the embryo. The stages of
gestation can be divided, at first approximation, into 3 developmental periods:
Early embryonic development, organogenesis, and late embryonic development.
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1. Early embryonic development; the embryo consists of relatively few cells,
which are still totipotent. This means that if they are moved to a different
site on/in the embryo, they will become what their new position dictates.
A teratogen which causes significant disruption of the embryo in early
embryonic development is usually lethal. Less drastic degrees of cell
death can be compensated, especially in the mammalian embryo, which
obtains nutrients through maternal transfer.
2. Organogenesis and early differentiation; this period is characterized by
rapid growth and differentiation of most organ systems. Extremely rapid
cell proliferation make the embryo particularly susceptible to teratogens,
since any decrease in nutrient levels, as well as cytotoxicity, can lead to
reduced cell number. Moreover, the increasing number of cells permits
survival of the embryo even after significant damage. The period of
organogenesis is the time when most structural teratogens induce their
effect.
3. Late embryonic development; this period is marked by growth, maturation
and functional differentiation of the organs formed in the previous stage.
Interference with development at this period leads to more subtle
structural malformations and to functional deficits, of which the most
dramatic is probably mental retardation. Functional deficits can be
induced in most organs even in the last trimester. The brain continues to
develop throughout prenatal life and for some time after birth, which
means that mental retardation can be induced from postnatal exposures,
e.g., from the maternal milk. Growth retardation may also be a
consequence of disturbances during this phase of development.
Figure 1. Relationship between developmental stage and sensitivity to
teratogenesis (from Tyl, 2000).
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Laboratory animals for teratogen testing
Animal-based studies of developmental toxicology provide the initial information
on whether a drug or chemical may present a teratogenic risk. Typically, a range
of doses administered via the most appropriate route is given to pregnant animals
during the period of embryonic organogenesis, and the outcomes compared to
control untreated animals. The most prevalent species used are mice, rats and
rabbits. The usual sample size is 20 individuals per dose, and the dose range is
selected so that the highest dose causes signs of toxicity, the lowest causes no
discernable effect in the foetus, and at least one intermediate dose.
Considering, physiological and biochemical differences between animal species
used in teratology research and humans, means that it is impossible for a single
species to have all desirable properties. Desired characteristics for the ideal
teratology animal have been proposed in a ‘wish list’, but no species comes close
to fulfilling the criteria. For example, no species absorbs, metabolises and
eliminates test substances like a human nor possesses the same placental transfer
properties; no one species has the same pre-term developmental and metabolic
patterns as humans; and, even if it were possible to meet all of these standards,
the animal would be unlikely to meet other ‘ideal’ criteria such as producing
large litters after a short gestation, inexpensive maintenance, and an inability and
unwillingness to ‘bite, scratch, kick, howl or squeal’ (Wilson, 1975).
Mammals
Rodents have become the most commonly used group for evaluating potential
human teratogens. Proponents of animal use, while admitting that it can only give
an approximation of effects in humans, praise the rat model since for many years
all human teratogens identified exhibited teratogenesis in rats (Tuchmann-
Duplessis et al., 1972). There are, however, important exceptions, such as with
the prostaglandin E1 analogue misoprostol: treatment of humans with this drug
for peptic ulcer disease or to initiate labour has a strong association with foetal
malformations known as Moebius syndrome (Pastuszak et al., 1998), but is not
teratogenic in the rat even up to 10 times the human dose (Klasco and Heitland,
2003). There are many examples of positive results in rodents that have little or
no effect in humans (‘false positives’), especially at normal exposures and
therapeutic dose levels. Notable examples include glucocorticoids and
benzodiazepines, which induce oral clefts in rats, mice and rabbits, but not in
humans (Baxter and Fraser, 1950; Buresh and Urban, 1970; Czeizel 1987;
Fainstat, 1954; Fraser and Sajoo, 1995; Miller and Becker, 1975; Pinsky and
DiGeorge, 1965; Rosenberg et al., 1983; Shepard 1994; Shiono and Mills, 1984;
Walker 1971; Wilson et al., 1970). Also aspirin, which causes cardiac
malformations in several species of animals, such as the rat and the rhesus
monkey, is harmless in man (Beall and Klein, 1977; Klein et al., 1981; Slone et
al., 1976; Werler et al., 1989; Wilson et al., 1977).
Because of the inherent problems and inadequacies of teratology testing and
research with the five groups of animals most commonly used (mouse, rat, rabbit,
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hamster, and monkey), scientists have tried to incorporate other species into their
experiments in an attempt to find something approaching that elusive ‘ideal
animal’. Dogs (more specifically beagles) were tested with an array of known
teratogenic compounds, but deemed unsuitable due to poor sensitivity; in any
case, it is known that many drugs are metabolised differently in the dog, and there
are particular problems with extrapolation from dogs to humans with reference to
steroids (Schardein, 1993). By using cats there was some promising concordance
with several compounds, though in common with dogs they are known to
metabolise a significant number of drugs differently, some uniquely, and there
were discordant results compared to other species with compounds such as
hydantoins, thalidomide, and especially the anti-leukaemia drug and abortifacient
aminopterin, which is highly teratogenic in humans but not at all in cats
(Schardein, 1993). Pigs were found to be as insensitive as dogs, ferrets did not
live up to early expectations, and non-human primates, despite their close
phylogenetic relationship to humans, have been particularly disappointing as a
predictive model (Schardein, 1993). Over 100 teratogenic agents classified as
‘possible’ or ‘probable’ have been tested in nonhuman primates, and the vast
majority showed a high level of discordance; of the known human teratogens
tested, only about half were found also to be teratogenic in one or more primate
species (Bailey et. al., 2005 ).
Amphibians
Amphibians have proven to be useful tools in both classical and modern
embryology. The African clawed frog, Xenopus laevis, has also been suggested as
a model for mammalian teratogenicity. Amphibian development is also used to
identify overall aquatic toxicity and the chemicals used for such studies tend to be
highly relevant to ecological problems.  Xenobiotics known to affect development
in amphibians include methyl mercury (5 to 30 ppb), high levels of selenium, the
fungicides dichlone and chloranil and benzo (a) pyrene.
Birds
Birds have proven important in all aspects of developmental biology and
toxicology. Chick embryos are excellent experimental subjects for embryologic
investigations, since they are easily obtained, can be maintained outside the egg
for at least 24 hours, and are large enough for easy manipulation. The effect of
DDT in thinning eggshells (Ratcliffe, 1967) and of PCBs in causing
malformations in birds, have been documented repeatedly. Recently, selenium
emerged to induce developmental malformations in birds (Ratti et al., 2006).
Chicken, duck and quail have been used most often in laboratory studies, but
correlations between pollutants in eggs and reproductive problems in wild birds
have been carried out in numerous species ranging from gulls to cormorants and
ospreys. It is quite clear that there is as much variability among avian as among
mammalian species in response to reproductive and development toxicants.
Chlorinated hydrocarbon insecticides, PCBs, and selenium, many or most
organophosphate insecticides (Ops) are potent teratogens in birds. The avian
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teratogenicity of organophosphates is in striking contrast to their inactivity in
mammalian development. Lead on the other hand, appears to be less toxic to
avian than to mammalian development.
Fish
Development in fish has been studied because of the economic importance of
many species and because fish are used as indicators in connection with
environmental assessment. Zebrafish, Japanese medaka, goldfish, rainbow trout
and fathead minnow are the most common laboratory species, which also are key
species promoted by OECD for future testing of chemical toxicity.
The zebrafish, Danio rerio, has been used extensively as a model species for
developmental biology. This species is small in size (3-5cm in length), easily
obtainable, inexpensive, readily maintainable, under appropriate conditions will
provide a large number of non-adherent and transparent eggs (Laale, 1997). One
female lays approximately 50 to 200 eggs per day. The morphological and
molecular basis of tissues and organ development in zebrafish are in general
either identical or similar to other vertebrates including men (Chen and Fishman,
1996; Granato and Nusslein-volhard, 1996). There is extensive similarity between
the zebrafish and human genomes so many human developmental and disease
genes have counterparts in the zebrafish. The zebrafish genome is 1700 million
base pairs in length, about half the size of the human genome.  Most human
genes have homologues to zebrafish and the functional domain of the protein
such as ATP binding domain of kinases are almost 100% identical between
homologous genes, although the similarity over the entire protein is about 60%
(Langheinrich, 2003). As protein function largely resides in functional domains
where drugs often binds, the zebrafish model is highly valid model for studying
drug effect in human.   Solvents, oil dispersants, pesticides and metals are known
to affect fish development deleteriously.
Teratogens
A teratogen is any medication, chemical, infectious disease, or environmental
agent that might interfere with the normal development of a foetus and result in
the loss of a pregnancy, a birth defect, or a pregnancy complication. There are a
variety of teratogens that are relatively common. Some examples are listed, but
there are other teratogens which are not on this list.
Recreational and Social teratogens
Two thirds of all infant mortalities are due to alterations in foetal development or
development during the first year of life. Often times, recreational drugs
significantly reduce foetal and post natal growth and are known to significantly
increase infant mortality, such as alcohol (Gilbert, 1997; O'Rahilly, 1992),
cocaine (Schardein, 1993), cigarettes (Klaassen, 1996). These teratogens usually
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disrupt foetal development before the mother knows she is pregnant and has a
chance to change her lifestyle.
Pharmaceutical teratogens
Most embryonic organs and the central nervous system are extremely sensitive to
the teratogenic affects of pharmaceuticals in the early development. Often times
these drugs causes embryonic malformations before the woman knows she is
pregnant. Thalidomide (Schardein, 1993), Diethylstilbestrol (Schardein, 1993),
Retinoic Acid (Schardein, 1993), Valproic Acid (Smith, 1982; Schardein, 1993),
Warfarin (Smith, 1982; Schardein, 1993), chemotherapy (Brent, 1986), lithium
(Gilbert, 2003; Stachel et al., 2003), nicotinic acid (Johnson and McColl, 1995)
etc are some examples of Pharmaceutical teratogens.
Industrial and Environmental teratogens
In the modern era where rapidly growing industries are fulfilling the needs of
growing population and has great economic importance, on the other hand these
industries are releasing a huge amount of waste products in the environment.
These waste products are not only polluting the environment but also leave severe
detrimental effects on the quality of life. Among these a lot of waste products
have teratogenic affects on the population such as organic solvents, chemicals,
arsenic (Wlodarczyk et al., 1996), cadmium and lead (Weiss et al., 1986),
anaesthetic gases, organic mercury(Harada, 1986) etc.
Agricultural teratogens
Studies have determined that insecticides (organochlorine insecticides) may
interfere with fertility and reproduction by mimicking estrogen-like compounds.
In some avian species, steroid metabolism is altered, making it impossible to
transport calcium to the developing egg shell. Insecticides have also been found to
accumulate and concentrate in the yolk sac of developing fish. Rodent studies of
DDT showed reduced testicular size in males and estrogenic effects in female
rats. Other teratogenic insecticides include dieldrin (reduction in fertility,
increased mortality, delayed ossification and increased supernumerary ribs) and
Kepone (reduction in sperm count and reduced motility).Herbicides, 2, 3, 7, 8-
tetrachloro-dibenzo-p-dioxin (TCDD) were used in 2, 4, 5-T teratological studies
resulting in cleft palate and congenital renal abnormalities.
Metabolic and Infectious Diseases
The TORCH complex is a group of similar malformations induced by microbial
teratogens. These microbes affect 1-5% of all live births and are among the
leading causes of neonatal morbidity and mortality. These organisms are Syphilis,
Cytomegalovirus, rubella (South et al., 1986), cytomegalovirus (Reynolds et al.,
1986), genital herpes, toxoplasmosis (Larsen, 1986), Fifth disease, and
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chickenpox. Some metabolic disorders also induce malformations in the embryos
e.g.   Diabetes, hyperthermia (high fever). General symptoms include premature
birth, growth retardation, neurological abnormalities, and damage of the eye,
liver, heart and ear as well as bone lesions. Microcephaly, hydrocephaly, seizures
and psychomotor retardation accompany these malformations.
On the basis of study documentation in animals and human and risk assessment
to human teratogens are classified into different categories as shown in the table
(A).
These categories are in agreement with FDA regulations as described in Millstein
(1980): Table (A)
Category A No demonstrated risk; possibility of foetal harm is remote.
Category B Either: no evidence of foetal risk in extrapolation from animal
data plus no information from human studies, or: evidence of
adverse effects in animal studies that could not be confirmed in
human
studies.
Category C Either: evidence of adverse effects in animal studies combined
with no studies in humans, or: studies in animals and humans are
not available.   Drugs only given to pregnant women when the
possible benefit outweighs the risks.
Category D Positive evidence of foetal risk. Drugs may be given to pregnant
women when the benefits are acceptable despite the risk.
Category E Known not to affect animal reproduction but no human data.
Category X Animal or human studies or human experience have revealed
foetal abnormalities.  Risk of use in pregnant women outweighs
any possible benefits.
Model substances for the experiment
Retinoic acid (RA)
RA is the acidified form of Vitamin A. It is a drug commonly used to treat acne
vulgaris and keratosis pilaris. In human foetus 13-cis-retinoic acid results in a
characteristic pattern of anomalies, including absent or defective ears, absent or
small jaws, cleft palate, aortic arch abnormalities, and abnormalities of the central
nervous system. Similar anomalies are observed in other mammals. In mice, for
example, embryonic exposure to retinoic acid results in axial truncation and
causes a dramatic reduction in the sizes of the first and second pharyngeal arches,
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which normally form the jaw, ear, and other facial bones (Gilbert, 2003; Ligas,
2000).
RA disrupts development by altering the expression of Hox genes, causing the re-
specification of the anterior–posterior axis and inhibition of neural crest cell
migration from the cranial region of the neural tube (Gilbert, 2003). RA cannot
bind directly to genes, so in order to affect gene expression, the RA molecule
needs to bind to specific RA receptors (RAR). After binding, the receptor becomes
an active transcription factor. The RA-bound RARs have at least two modes of
action, one of which is to bind to their DNA enhancer sequences and activate
particular genes that are not usually activated in these cells. These genes include
certain homeotic genes that specify the anterior-posterior position along the body
axis. In this way, they can cause homeotic transformations, generally converting
anterior structures into more posterior structures (Gilbert, 2003). In the embryo,
there is a gradient of retinoic acid from the anterior end to the posterior end.
Excess RA results in a posterior region having a higher than normal level of RA,
and so more anterior Hox genes are expressed in typically posterior regions
(Ligas, 2000).
Lithium
Lithium, in the form of lithium carbonate, is regularly prescribed to people with
manic depressive (Bipolar) disorder. It takes the peaks and the valleys out of the
emotional swings that a person with disease suffers, and is thought to do so
through its control of receptors for the neurotransmitter glutamate. Since late
1800s embryologist have known from studies on non human embryos that lithium
causes severe developmental defects. The attribute teratogenic effects are
increased risk of heart defects especially Ebstein’s anomaly which affects the
tricuspid valve and seriously compromises heart ability to function effectively.
Spina bifida and floppy infant syndrome are also reported defects.
In studies on non human embryos, the developmental defects caused by lithium
are  clear.  As  early  as  1982  Herbst  studied  that  echinoderm  embryos  exposed  to
lithium salts undergo exogastrulation. More recently it has been shown that both
Xenopus and zebrafish embryos exposed to lithium during cleavage stages are
dorsalized, showing severe defects in the posterior region (Gilbert, 2003; Stachel
et al., 2003). These teratogenic defects are caused by lithium’s inhibition of
glycogen synthase kinase in the Wnt/β catenin or by depletion of inositol
triphosphate in the PIP (phosphoinositol pathway) cycle as the dorsal-ventral axis
is being established (Klein and Melton, 1996; Stachel et al., 1993; Baraban,
1994). In the zebra fish, later exposure (at the eleventh cleavage through
gastrulation) causes anterior defects especially of the eyes, in some cases causing
a lack of eyes altogether (Stachel et al., 1993).
Ethanol
Ethanol, widely consumed as a recreational drug, has long been strongly
associated with teratogenesis as FAS (Jones et. al., 1973). FAS present up to one
in three children of alcoholic mothers. FAS manifestations include growth
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deficiency, CNS problems, characteristic facial features and organ malformations
(Streissguth et al., 1995; Gilbert, 1997; Cartwright and Smith, 1995; Smith,
1997; Sulik et al., 1988). Each year, up to 40000 babies are born with some
degree of alcoholic related damage (Sokol et. al., 2003).
Ethanol is able to permeate the placenta and enter foetal circulatory system,
thereby causing developmental abnormalities.  Ethanol impairs placental blood
flow to the foetus by constricting blood vessels which induce hypoxia and foetal
malnutrition. Ethanol rapidly crosses the placenta and blood brain barrier of the
foetus. There are many proposed mechanism of action for ethanol such as altered
neural crest cell migration, increased neural crest cell death or general cell death
by superoxide radial lysis of cells or mitochondrial cell dysfunction. Ethanol may
inhibit growth factor regulating cell proliferation and survival effects on Glial
cells effects on development of neurotransmitter systems.
In zebrafish ethanol is responsible for abnormal migration of prechordal plate
cells that ultimately causes cyclopia and other deformities (Blader and Strähle,
1998). The prechordal plate cell expressed genes like goosecoid and Islet 1, which
control cell differentiation in the anterior region of the embryo (Blader and
Strähle, 1998). Sulik (1988) studied that ethanol appears to cause abnormal cell
death. Ethanol achieves apoptosis by activating the cell’s self destruction
machineries (Sulik et al., 1988). Therefore in addition to ectopic prechordal
plates specific gene expression, ethanol induced apoptosis appears to contribute to
the observed deformities in zebrafish embryos (Sulik et al., 1988).
6-Aminonicotinamide (6-AN)
6-Aminonicotinamide is a potent niacin antagonist (Johnson and McColl, 1995)
having carcinostatic and  teratogenic effects.6-AN  is a reported teratogen in
laboratory animals and induce cleft lip, stunted growth and hind limb defects in
mice (Pinsky and Fraser ,1960) and similar malformations were observed in
rabbit . Nicotinamide is transferred actively across the placenta (Hill and Longo,
1980; Kaminetzky et al., 1974) and into breast milk (Deodhar et al.,
1964).Abnormal neural tube closure defects and other abnormalities were
observed in chick when eggwhite was replaced with a solution containing 20 mg
of nicotinic acid (Hansborough, 1974).
6-AN induce teratogenesis by inhibiting nicotinamide adenine dinucleotide
dependent reactions during ATP synthesis. (Wilson et al., 1975; Dietrich et al.,
1958).
Ochratoxin A (OA)
OA is an important food borne mycotoxin and is a potent teratogenic agent
produced by several species of aspergillus and pencillium. OA is a reported
teratogen in rats (Brown et. al.,1976; Mayura et al.,1982), mice (Hayes et
al.,1974), Hamsters (Hood et al.,1976) and chicken (Gilani et al.,1975)
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OA inhibits protein synthesis by competition with the amino acid phenylalanine
(Phe) in the phenylalanyl-tRNA synthetase-catalyzed reaction (Bunge et al.,
1978; Creppy et al., 1979).At post transcriptional level with OA having a direct
effect on the translation step in the protein synthesis. This involves the
competitive inhibition of phenylalanine-tRNA synthetase, so that aminoacylation
and peptide elongation are stopped (Creppy et. al., 1979; WHO series28).
Manolova et al., (1990) described that one possible way of OA induction of
teratogenesis is chromosomal aberrations by conducting positive in vitro
experiment on human lymphocytes.
OA-DNA adducts formation in different parts of the foetus e.g. liver, kidney and
other tissues, is a suggested mechanism of teratogenesis for OA by many scientist
(Pfohl-Leszkowicz et al., 1991, 1993; Grosse et al., 1995, 1997; Castegnaro et al.,
1998; Pfohl-Leszkowicz et al., 1998).
Arsenic
Arsenic, a metal pollutant found naturally in groundwater and unnaturally in
mine waste sites and agricultural runoff, has been considered toxic to humans for
several millennia. Arsenic is teratogenic, and it has been shown to cross the
mammalian placenta, affecting developing embryos whose mothers undergo
exposure (Wlodarczyk et al., 1996).
Arsenic has been found to cause high mortality, miscarriage, stillbirth,
developmental retardation and birth defects in humans (Shalat et al., 1996);
neural tube, ocular and jaw defects (Stump et al., 1999) and behavioural
retardation and delayed ear detachment (Rodriguez et al., 2002) in rodent
embryos; and everted internal organs and small eyes in chicks (Shalat et al.,
1996). Neural tube defects have been identified as a common defect among
mammals, possibly reflecting the fact that arsenic accumulates in the
neuroepithelium of developing fetuses (Shalat et al., 1996). Inorganic arsenic, of
which sodium arsenate and arsenic trioxide are two kinds, may cause neural tube
defects by repressing cell replication through microtubule organization or by
inhibiting cell shape changes necessary to neural tube formation (Shalat et al.,
1996). Wlodarczyk and co-workers (1996) suggest that arsenic damaging of DNA
is responsible for inhibition of cell propagation, thus delaying and preventing a
normal neural tube closure.
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Aim of the study
The  aim  of  the  present  study  was  to  assess  the  potential  of  the
zebrafish as a laboratory animal model for teratogen testing. Potential
human teratogens i.e. Retinoic Acid , Lithium Hydroxide, Ethanol,
Arsenic Oxide, Ochratoxin A and  6–Aminonicotinamide were used
on zebrafish embryos. Results of the study were compared with the
results of other laboratory animals
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Abstract
Teratology, the study of abnormal prenatal development and congenital
malformations induced by exogenous chemical and physical agents, is one of the
debating areas of medical research in the quest for the eradication of preventable
birth defects. Identification of agents with teratogenic potential from the huge
amount of drugs that human being come into contact within their every day
environment is crucial because they are compromising the quality of life for
millions of people world wide. Since the thalidomide catastrophe in 1961
regulatory agencies have instigated requirements for new drugs to be thoroughly
tested on animals prior to approval for marketing. Different laboratory animals
mainly rat, mice, rabbit, primates are being used for chemicals teratogenicity tests
but none of these laboratory animal models fulfil the criteria for ideal
experimental model. In the recent times zebrafish has emerged as a prominent
developmental study model.
 Fertilized eggs of zebrafish were used to test teratogenicity of chemicals.
Zebrafish embryos were cultured in 96 -well plates, with a range of different
concentrations of the chemicals, a method described by Schulte and Nagel (1994).
The following parameters of the development of Danio rerio were observed at
every 24hpf until 144hpf: coagulation of eggs, hatching, movement, circulation,
heart rate, pigmentation, development of eyes, fins and tail, and yolk sac oedema.
Six chemicals from different teratogenic classes (retinoic acid, lithium hydroxide,
Ochratoxin A, 6-aminonicotinamide, sodium arsenate and ethanol) were selected
for the teratogenic testing in the zebrafish embryos. The developmental defects
induced by these chemicals in zebrafish embryos were studied. The results were
compared with other laboratory animal’s available data about the substances. All
chemicals except sodium arsenate induced severe developmental defects among
zebrafish embryos.
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Introduction
Teratology, the study of abnormal prenatal development and congenital
malformations induced by exogenous chemical or physical agents, is a growing
area of medical research in the quest for the eradication of preventable birth
defects. Birth defects are known to occur in huge numbers roughly seven to ten
percent of all children require extensive medical care to diagnose or treat a birth
defect, this compromise the quality of life for millions of people world wide
(Dicke, 1989). Identification of agents with teratogenic potential from the huge
amount of drugs and chemicals that human being come into contact with in their
everyday environment in crucial. It is estimated that 10% of all birth defects are
caused by a prenatal exposure or teratogen (O'Rahilly, 1996). A good knowledge
about these hazardous substances would enable medical professionals and would-
be mothers to minimize foetal exposure to them. This will help in achieving the
laudable goal of abolishing teratogen- induced malformations.
 Since Thalidomide catastrophe in 1961 (Mc Bride, 1961; Lenz, 1966) regulatory
agencies such as United States Food and Drug Administration (FDA) instigated
requirements for new drugs to be thoroughly tested on animals prior to approval
for marketing. Currently the burden of identifying of human teratogens has rested
squarely on the shoulders of animal-based research. Animal-based studies of
developmental toxicology provide the initial guideline whether a drug or chemical
may present a teratogenic risk during pregnancy. The most prevalent species used
are mice, rats, rabbits, hamsters and primates, but no one species fulfilling the
ideal teratology animal criteria such as “producing large litters after a short
gestation, in expansive maintenance and inability and unwillingness to ‘bit,
scratch, kick, howl, squeal’”. Scientist are still exploring new alternative for
teratogen testing. Recently zebrafish (Danio rerio) has emerged as a competitive
laboratory animal model species and has been used as a model species for
developmental biology.
The zebrafish (Danio rerio) (Hamilton-Buchanan, 1922; formally Brachydanio
rerio) is a small cyprinid found in tributaries and branches of the Ganga river in
South-East Asia (Eaton and Farley, 1974). This species measures 3 to 5 cm as an
adult and thrives both in soft and hard water. At 26°C zebrafish grow quickly and
reaches maturity within 3 months (Skidmore, 1967).
Zebrafish is easily obtainable, inexpensive and readily maintainable. Under
appropriate conditions it provides a large number of non-adherent and
transparent eggs i.e. approximately 50 to 200 eggs per female per day (Laale,
1977). Zebrafish embryonic development has been described in numerous studies
and has been used as model in numerous fields of molecular genetics, vertebrate
developmental biology, neurobiology and transgenic research (Roosen-Runge,
1938; Thomas and Waterman, 1978; Kimmel et at., 1988; Hisaoka and Battle,
1958; Laale, et al., 1977; Sander and Baumann, 1983; Nagel, 1988; Kimmel et
al., 1995; Nusslein-Volhard, 1994; Westerfield, 1995; Lele and Krone, 1996;
Goolish et al., 1999; Wixon, 2000). From the last decade of 20th century and start
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of 21st century  studies  showed  that  the  zebrafish  has  become  one  of  the  most
important models for vertebrate developmental biology (Ekker and Akimenko,
1991; Nusslen- Volhard, 1994; Westerfield, 1995).
 There are numerous advantages for the use of zebrafish as a toxicological model
species (Spitsbergen and Kent, 2003; Teraoka et al., 2003) as well as for other
disciplines. This is evident by the number of publications about zebrafish studies
in  the  recent  past.  In  early  1990s  there  was  less  than  one  hundred  zebrafish
publications annually submitted. This rose to around about thousands at the turn
of the century and now the average is around 3500 per year.
In contrast to other vertebrate models the zebrafish model has great benefits with
regards to their sizes, husbandry and early morphology. Zebrafish has high
fecundity, small size (3 to 5cm), short generation time, rapid development,
external fertilization, translucent embryos and is easy to maintain at laboratory
level (Laale, 1997). This greatly reduces housing space and husbandry cost.
Zebrafish has also been utilized as a laboratory species for quite some time, so the
optimum breeding and maintenance conditions have been well documented
(Westerfield, 1995). In contrast to larger laboratory species the minute size of
larval and adult zebrafish minimizes costs through low quantities of dosing
solutions (Only nanogram quantities of experimental chemicals, drugs and
pollutants) and thereby creates limit volumes of waste for disposal. Small size of
zebrafish minimize the quantity of labware and chemicals both for treating and
maintaining live fish and for performing various assay (low quantities of reagents
and histological assessments, small amount of embedding materials and
microscope slides) (Hill et al.,2002). Small embryos allow reasonable sample size
and several experimental replicates at one time. The zebrafish embryos can grow,
develop and survive for several days in a single well of a 384-well plate and 96-
well plate through the absorption of yolk and can be visually assessed for
malformations (Nagel, 1993; Mac Rae and Peterson, 2003). The zebrafish embryo
is completely transparent so it facilitates visual multi-parameter observation and
analysis at a time. In one screen the cardiovascular system, central nervous
system and skin can be assessed with a dissection microscope (Peterson et al.,
2000). Zebrafish embryo’s entire body plan develop by in 24 hours and all the
precursor cell and the tissues of the brain, eyes, heart and musculature can be
easily visualized using light microscope. The zebrafish completes embryogenesis
in the first 72 hours and most of the internal organs including the cardiovascular
system, gut, liver, and kidney develop rapidly in the first 24 to 48 hours (Stainier
and Fishman, 1994). Unlike rodents, embryological development can be
continually followed in live individuals rather than in harvested embryos and
foetuses. In addition, zebrafish embryos that are malformed, missing organs, or
displaying organ dysfunction, can usually survive substantially past the time in
which those organs start to function in healthy individuals. For example, mutant
zebrafish such as silent heart, still heart, and slow mo (Chen et al., 1996), and
toxicant-exposed embryos with heart abnormalities (Antkiewicz et al., in press;
Incardona et al., 2004) survive well beyond 24hpf when the heart normally begins
to beat (Kimmel et al., 1995). This is in contrast to rodent embryos with
malformed hearts that tend to die in utero. An important advantage of zebrafish
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model is that the morphological and molecular basis of tissues and organ
development are in general either identical or similar to other vertebrates
including men (Chen and Fishman, 1996; Granato and Nusslein-volhard, 1996).
There is extensive similarity between the zebrafish and human genomes so many
human developmental and disease genes have counterparts in the zebrafish. The
zebrafish genome is 1700 million base pairs in length, about half the size of the
human genome. Most human genes have homologues to zebrafish and the
functional domain of the proteins such as ATP binding domain of kinases are
almost 100% identical between homologous genes, although the similarity over
the entire protein is about 60 % (Langheinrich, 2003).
In the present study, the teratogenicity of six chemicals was studied by using
fertilized eggs of the zebrafish (Danio rerio). These chemicals were selected from
different categories of potential human teratogens with different mechanisms of
action to induce teratogenesis. Ethanol, widely consumed as a recreational drug,
has long been strongly associated with teratogenesis as foetal alcohol syndrome
(FAS) (Jones et. al., 1973). FAS is present up to one in three children of alcoholic
mothers. FAS manifestations include growth deficiency, CNS problems,
characteristic facial features and organ malformations (Streissguth et al., 1995;
Gilbert, 1997; Cartwright and Smith, 1995; Smith, 1997; Sulik et al., 1988). To
induce malformations ethanol alters the mechanism of cell migration in the
developing foetus (Blader and Strähle, 1998) and in some times cell death (Sulik
et al., 1988). Retinoic acid (RA) is the acidified form of Vitamin A. It is a drug
commonly used to treat acne vulgaris and keratosis pilaris. In human foetus 13-
cis-retinoic acid results in a characteristic pattern of anomalies, including absent
or defective ears, absent or small jaws, cleft palate, aortic arch abnormalities, and
abnormalities of the central nervous system. RA disrupts development by altering
the expression of Hox genes, causing the re-specification of the anterior–posterior
axis and inhibition of neural crest cell migration from the cranial region of the
neural tube (Gilbert, 2003). Lithium, medicine for manic depressive (Bipolar)
disorder, causes severe developmental defects the attribute teratogenic effects are
increased risk of heart defects especially an Ebstein’s anomaly which affects the
tricuspid valve and seriously compromises heart ability to function effectively.
Spina bifida and floppy infant syndrome are also reported defects. These
teratogenic defects are caused by lithium’s inhibition of glycogen synthase kinase
in the Wnt/β catenin and by depletion of inositol triphosphate in the PIP
(phosphoinositol pathway) cycle as the dorsal-ventral axis is being established
(Klein and Melton, 1996; Stachel et al., 1993; Baraban, 1994). Arsenic, a metal
pollutant, cause high mortality, miscarriage, stillbirth, developmental retardation
and birth defects in humans that include neural tube, ocular and jaw defects
(Stump et al., 1999; Shalat et al., 1996). Wlodarczyk et. al. (1996) suggested that
arsenic damaging of DNA is responsible for inhibition of cell propagation, thus
delaying and preventing a normal neural tube closure. Ochratoxin A (OA) ,a food
borne mycotoxin, is a reported teratogen in rats (Brown et. al.,1976; Mayura et
al.,1982), mice (Hayes et al.,1974), Hamsters (Hood et. al.,1976) and chicken
(Gilani et al.,1975). The mechanism of teratogenesis of OA is to inhibit protein
synthesis by competition with the amino acid phenylalanine (Phe) in the
phenylalanyl-tRNA synthetase-catalyzed reaction (Bunge et al., 1978; Creppy et
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al., 1979). 6 -Aminonicotinamide is a potent niacin antagonist (Johnson and
McColl, 1995) having carcinostatic and teratogenic effects.6-AN is a reported
teratogen in laboratory animals and induce cleft lip, stunted growth and hind limb
defects in mice (Pinsky and Fraser, 1960). 6-AN induce teratogenesis by
inhibiting nicotinamide adenine dinucleotide dependent reactions during ATP
synthesis (Wilson et al., 1975).
The aim of the present study was to observe the potential of zebrafish as a
laboratory animal species for teratogen testing by using the above mentioned
human potential teratogens. Results of the study were compared with the results
of other laboratory animal species.
Materials and method
Test material
Six different chemicals with known potential human teratogenicity were used for
the study, these chemical were bought from the respective companies as shown in
the table (a). Experiments were performed at the Department of Biomedical
Sciences and Veterinary Public Health, Division of Pathology, Pharmacology and
Toxicology, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Animals
Fertilized eggs of zebrafish (Danio rerio; cyprinidae, Hamilton-buchanan 1822)
were used. Adult zebrafish (Danio rerio), originally bought from a local importer
(akvarium kalhäll, Jakobsberg, Sweden), were adapted in the fish laboratory at
the Department of Biomedical Sciences and Veterinary Public Health, Division of
Pathology, Pharmacology and Toxicology, Swedish University of Agricultural
Chemical Trade name Company Chemical
formula
Molecular
weight
Retinoic acid Tretinoin® F. Hoffmann-La
Roche Ltd,
Switzerland
C20H28O2 300.42
Lithium hydroxide LiOH 98%® E.Merck,Germany  LiOH 23.95
Ochratoxin A  Ochratoxin A® Fluka AG,chem.
Switzerland
C20H18ClNO6 403.81
Ethanol 96% C2H5OH 46.07
6-Amino
nicotinamide
6-Aminonicotin
amide, purum,
Fluka AG, chem.
Switzerland
≥99.0% (NT) ®
C6 H7 N3 O 137.14
Arsenic Sodium arsenate
dibasic  hepta
hydrate ≥98.0%
Sigma-Aldrich Na2HAsO4 ·
7H2O
312.01
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Sciences, Uppsala , Sweden. The fish were kept in the laboratory at a temperature
of 26±1°C and 12:12 hours day/night regimen. The fish were fed twice a day with
sera micron (Sera ®, Germany), Artemia nauplii and powdered freeze-dried red
grubs  (Nutrafin  ®,  Taiwan).  ).  The  fish  were  kept  in  constantly  aerated,
standardised water (CaCl2x2H2O (117.6 mg/litre), MgSO4x7H2O (49.3 mg/litre),
NaHCO3 (25.9 mg/litre) and KCl (2.3 mg/litre)) (ISO 7346-1, 1996).
Test design
On the day before the experiment, phenotypic zebrafish females (5-10) and males
(10-20) from the main aquarium were transferred to a breeding funnel with 15L
standardised water. A net cage with 4mm holes was kept in the breeding funnel to
keep  adult  zebrafish  away  from  the  eggs.  In  the  morning,  once  the  light  was
turned on, the fish begun to mate. The eggs were collected after 30 minutes from
the bottom tap of the breeding funnel and rinsed twice in standardised water
.Fertilized eggs were selected with a dissecting microscope. After egg collection,
the adult zebrafish were returned to the main aquarium.
Exposure and embryo developmental test
Fertilized eggs that had reached the four cell stage were exposed to a range of
concentrations of potential human teratogenic substances.
Retinoic acid (10-9 M, 10-8M, 10-7.8M, 10-7.6M, 10-7.4M, 10-7.2M, 10-7M)
Lithium hydroxide (1x10-2M,2x10-2M, 3x10-2M, 4x10-2M, 8x10-2M, 12x10-2M,
16x10-2M)
Ochratoxin A (0.5x10-7M, 1x10-7M, 2x10-7M, 3x10-7M, 6x10-7M, 12x10-7M,
25x10-7M)
6Aminonicotinamide (0.5x10-6M, 1x10-6M, 3.5x10-6M, 7x10-6M, 14x10-6M,
22x10-6M, 29x10-6M)
Sodium arsenate (1.5x10-3M,3x10-3M,6x10-3M,9x10-3M,12x10-3M,15x10-3M)
Ethanol (0.5%, 1%, 1.25%, 1.5%, 1.75%, 2%, 2.5%)
This method was described by Schulte and Nagel (1994). Selected fertilized eggs
that had reached the four cell stage were transferred into the individual u–shaped
wells of 96 well styrene plate (costar, coring incorporated, USA) by the use of a
pipette filled with rearing media. DMSO was used as a solvent for RA and OA;
all other substances were water soluble. Each well contained 250μl rearing media
which was not changed during the study. 24 eggs were used per concentration
group and the study was done twice for each substance. The styrene plates were
covered with plastic sheets to avoid evaporation and were incubated at a constant
temperature of   26ºC. Embryos were examined under dissecting microscope after
 38
every 24 hours for 6 days, after which the embryos were euthanized with MS-222
(200mg/liter) solution. Microscopic examination was performed by use of a light
source equipped with a fiber optic cable to prevent temperature stress of the
embryos.
Statistics
Heart rate was analysed statistically using one way ANOVA followed by
Dunnett's post hoc test. Hatching and coagulation were analysed by fisher exact
test. All other ordinal parameters were analysed by using Kruskal-Wallis test
followed by Mann-Whitney test, where each group was compared with respective
control group. No observed effect concentration (NOEC) and lowest observed
effect concentration (LOEC) were calculated. The significance level was set at
0.95 (P<0.05). The analyses were made by using Statview 5.0.1 (SAS institute
Inc.) and MINITAB release 14 (Minitab Inc.). Sidan:32.
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End points of the study
 Endpoints studied at different stages of the development in zebrafish embryos;
Endpoint Description 24hpf 48hpf 72hpf 96hpf 120hpf 144hpf
Coagulation Embryo coagulation + + + + + +
0=no coagulation
1=coagulated
Movement Movement within 30
seconds + + + + + +
1=normal movement.
2=sluggish movement
3=no movement at all
Heart rate Beats/minutes +
Circulation Visible blood flow in  tail
region + + + + +
1=normal flow
2=affected circulation
3=no circulation
Oedema Oedema around the body + + + + + +
0=no oedema
1=slight oedema in  heart
region
2=moderate oedema in
heart rate
3=severe oedema in heart
region
4=severe oedema involving
whole body.
Eyes Size and colour of eyes + + + + + +
1=normal size and colour
2=relatively small size
3=very small or no eyes at
all.
Tail extension Length of tail, separation
from yolk sac + + + + + +
1=normal tail
2=relatively short tail
3= very short tail and
attached to yolk sac
Pigmentation Pigmentation in the body + + + + +
1=normal pigmentation
2=slight pigmentation
3=no pigmentation
Hatching Embryo hatching
0=not hatched + + + +
1=hatched
Fins Length of fins + + +
1=normal length
2=small fins
3=no fin development
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Results
Embryos were continuously monitored till 144hpf. Readings of the selected end
points were taken after every 24 hours for 6 days. For the statistical analysis data
taken by 48hpf and 144hpf were selected because most of the studied end points
were developed by 48hpf and heart rate was easy to count, and 144hpf was the
study termination point.
Retinoic acid
Zebrafish embryos treated with RA at concentrations of 10-8M and 10-9 M
presented no apparent developmental abnormalities. By approximately 48hpf, the
embryos displayed no evidence of truncation and had apparently normal
development. Normal development was observed 2 to 3 days after treatments. By
which most of embryos had hatched. No difference in heart rate was observed
with respect to control group (Table I). The interior and posterior regions of
embryos developed similarly to that of control. These embryos survived until
euthanized.
The embryos treated with higher concentrations of RA10-7.8M and 10-7.6M were
severely affected. These embryos presented truncation of the interior and posterior
axis by 48hpf. Heart rate of these embryos was significantly different from the
control group. The yolk sacs were on average noticeably larger than those of the
control embryos. Embryos treated with 10-7.4M, 10-7.2M, 10-7M had severe under
development and larger oedema, no movement, no circulation, small eyes, short
tail. Most of the embryos treated with these concentrations of RA died by the 3rd
day after treatment (Table I).
Table text
(* = significant different)
(- = no statistically significant data)
(HR = Heart rate beats/minute)
(HPF = hours post fertilization)
(Median values for all ordinal parameters and mean values for heart rate)
(Statistical analysis was done for the results when at least 5 embryos were alive
out of 24 individuals)
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Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching HR(mean)
Retinoic acid 48hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 138.5
10-9 M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 134.5
10-8M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 135.5
10-7.8M 0.0 1.0 1.0 1.0* 1.0 1.0 1.0 0.0 125.5*
10-7.6M 0.0 1.0 2.0* 1.0* 1.0 1.0 1.0 0.0 117.5*
10-7.4M 0.0 2.5* 3.0* 3.0* 2.0* 2.0* 2.0* 0.0 -
10-7.2M 0.0 3.0* 3.0* 3.0* 3.0* 2.0* 2.0* 0.0 -
10-7M 0.0 3.0* 3.0* 4.0* 3.0* 2.0* 2.0* 0.0 -
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching Fins
Retinoic acid 144hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
10-9 M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
10-8M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
10-7.8M 0.5* 2.5* 1.0 2.0* 1.5* 1.0 1.0 1.0 1.0
10-7.6M 0.5* 3.0* 2.5* 2.5* 2.0* 2.0* 1.0 1.0 1.5*
10-7.4M 0.5* 3.0* 3.0* 3.0* 3.0* 2.0* 2.0* 1.0 3.0*
10-7.2M 1.0* 3.0* 3.0* 3.0* 3.0* 2.0* 2.0* 1.0 3.0*
10-7M 1.0* - - - - - - - -
Table (I); Statistical analysed studied end point results for RA by 48hfp and 144hpf.
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                     A
                        B
Figure (A) 10-7.4 M RA treated embryos by 144hpf. No development of eyes, very
short  tail,  yolk  sac  oedema  and  not  hatched  (B) 10-7.8M RA treated embryos by
144hpf. Microphthalmia and yolk sac oedema.
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Lithium hydroxide
Zebrafish embryos treated with LiOH at the concentration (1x10-2M, 2x10-2M,
3x10-2M, 4x10-2M, 8x10-2M, 12x10-2M and 16x10-2M) showed normal
development and presented no apparent developmental abnormalities by 48hpf.
By approximately 144hpf, embryos treated with 1x10-2M, 2x10-2M and 3x10-2M
continued normal development as to that of control group. Most of the embryos
treated with 4x10-2M ,8x10-2M and12x10-2M  coagulated  by  day  six  and  no
coagulated embryos showed affected movement, no circulation and severe
truncation of interior and posterior axis. Most of the embryos exhibited scoliosis.
Coagulation rate was less among the embryos treated with 16x10-2M but they had
developed severe developmental abnormalities by 144hpf i.e. no movement, no
circulation, small eyes, short tail, under developed fins and scoliosis (Table II).
Figure. 12x10-2M Lithium hydroxide treated embryo after 144hfp.
Microphthalmia, yolk sac oedema and relatively short tail.
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Table (II); Statistical analysed studied end point results for Lithium hydroxide by 48hfp and 144hpf.
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching HR(mean)
Lithium
hydroxide 48hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 136.5
1x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 134.5
2x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 135.5
3x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 133.5
4x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 132.5
8x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 135.5
12x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 132.5
16x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 132
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching Fins
Lithium
hydroxide 144hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
1x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
2x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
3x10-2M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
4x10-2M 0.0 3.0* 3.0* 2.5* 1.0 1.0 1.0 1.0 2.5*
8x10-2M 1.0* 3.0* 3.0* 3.0* 1.0 1.0 1.0 1.0 3.0*
12x10-2M 1.0* 3.0* 3.0* 3.0* 2.0* 2.0* 1.0 1.0 3.0*
16x10-2M 0.0 3.0* 2.5* 3.0* 2.0* 2.0* 1.0 1.0 3.0*
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Ethanol
Development was normal among the zebrafish embryos treated with 0.5 %, 1 %
and 1.25 % ethanol by 48hpf (Table III). Affected circulation and moderate yolk
sac oedema was observed among the zebrafish embryos treated with 1.75% and
1.5% by 48hpf. Zebrafish embryos treated with 2% and 2.5% ethanol develop
severe developmental abnormalities i.e., lower heart rate, affected circulation,
moderate to severe yolk sac oedema, microphthalmia to anophthalmia and
affected tail development by 48hpf (Table III).
By approximately 144hpf embryos treated with 0.5% and 1% ethanol developed
normally and presented no developmental abnormalities. 60% of the embryos
treated with 1.25% ethanol coagulated and no coagulated embryos showed only
slight yolk sac oedema and others parameters were normal. 70-80% of the
embryos treated with 1.5% and 1.75% ethanol were coagulated and no coagulated
embryos showed severe oedema, lack of movement, microphthalmia and under
developed fins. All embryos treated with 2 %and 2.5% ethanol were coagulated
by the sixth day (table III).
Figure. 2.5% Ethanol treated embryo after 72hfp. Large yolk sac oedema and
no development of eyes and tail.
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Table (III); Statistical analysed studied end point results for ethanol by 48hfp and 144hpf.
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching HR(mean)
Ethanol 48hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 140.5
0.5% 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 137.5
1.0% 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 138.0
1.25% 0.0 1.0 1.0 1.0* 1.0 1.0 1.0 0.0 137.5
1.5% 0.0 1.0 2.0* 2.0* 1.0 1.0 1.0 0.0 136.5
1.75% 0.0 1.0 1.5* 2.0* 1.0 1.0 1.0 0.0 124.5*
2.0% 0.0 2.0* 2.0* 2.0* 1.5* 1.5* 1.0 0.0 118.5*
2.5% 0.5* 3.0* 3.0* 4.0* 3.0* 3.0* 1.5* 0.0 -
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching Fins
Ethanol 144hpf
Control 0.0 1.0 1.0 0 1.0 1.0 1.0 1.0 1.0
0.5% 0.0 1.0 1.0 0 1.0 1.0 1.0 1.0 1.0
1.0% 0.0 1.0 1.0 0 1.0 1.0 1.0 1.0 1.0
1.25% 0.5* 1.0 1.0 1.0* 1.0 1.0 1.0 1.0 1.0
1.5% 1.0* 1.0 1.0 2.0* 2.0* 1.0 1.0 1.0 2.0*
1.75% 1.0* 3.0* 3.0* 2.5* 3.0* 2.0* 2.0* 0.5* 3.0*
2.0% 1.0* - - - - - - - -
2.5% 1.0* - - - - - - - -
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6-Aminonicotinamide
By 48hpf zebrafish embryos cultured in higher concentrations of 6-AN (7x10-6M,
14x10-6M, 22x10-6M and 29x10-6M) showed developmental abnormalities, i.e.
moderate yolk sac oedema , lack of movement, affected eyes. Lower pigmentation
was observed only in 29x10-6M treated embryos (Table IV). Some embryos
treated with 3.5x10-6M lacked spontaneous movement and developed slight
oedema around the yolk sac by 48hpf. Normal development was observed among
the zebrafish embryos treated with 0.5x10-6M and 1x10-6M treatment of 6-AN by
48hpf and 144hpf. Embryos treated with 3.5x10-6M, 7x10-6M, 14x10-6M, 22x10-
6M and 29x10-6M showed severe developmental abnormalities by 144hpf, i.e. no
movement, microphthalmia, severe yolk sac oedema and 15-20% coagulation
rates in all groups and lower pigmentation only in 29x10-6M treated embryos.
Hatching was also affected and embryos treated with 14x10-6M, 22x10-6M and
29x10-6M showed lack of hatching (Table IV).
A
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                                 B
Figure (A) 22x10-6M 6-AMN treated embryo after 144hpf. No hatching and no
development of eyes (B) 3.5x10-6M 6-AMN treated embryo after 144hpf. Yolk
sac oedema, relatively short tail and eyes as compare to control embryos.
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Table (IV); Statistical analysed studied end point results for 6-AN by 48hfp and 144hpf.
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching
HR
(mean)
6-
Aminonictinamide 48hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 140.5
0.5x10-6M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 137.5
1x10-6M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 139.0
3.5x10-6M 0.0 1.5* 1.0 1.0* 1.0 1.0 1.0 0.0 137..0
7x10-6M 0.0 2.0* 1.0 2.0* 1.5* 1.0 1.0 0.0 132.5*
14x10-6M 0.0 3.0* 1.0 2.0* 2.0* 1.0 1.0 0.0 124.5*
22x10-6M 0.0 3.0* 2.0* 2.0* 2.0* 1.0 1.0 0.0 120.5*
29x10-6M 0.0 3.0* 2.0* 2.0* 2.0* 2.0* 2.0* 0.0 115.5*
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching Fins
6-
Aminonictinamide 144hpf
Control 0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
0.5x10-6M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
1x10-6M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
3.5x10-6M 0.5* 2.0* 2.0* 2.5* 2.0* 2.0* 1.0 1.0 2.5*
7x10-6M 0.5* 3.0* 3.0* 3.0* 2.0* 2.0* 1.0 1.0 3.0*
14x10-6M 0.5* 3.0* 3.0* 2.0* 2.0* 2.0* 1.0 0.0* 3.0*
22x10-6M 0.0 3.0* 3.0* 2.0* 3.0* 2.0* 1.0 0.0* 3.0*
29x10-6M 0.0 3.0* 3.0* 3.0* 3.0* 2.0* 2.0* 0.0* 3.0*
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Ochratoxin A
At higher concentrations of OA (6x10-7M, 12x10-7M and 25x10-7M) by 48hpf
embryos showed developmental abnormalities, i.e. oedema, affected circulation
and significantly lower heart rate in 12x10-7M and 25x10-7M treated embryos.
Embryos treated with lower concentrations 0.5x10-7M, 1x10-7M, 2x10-7M and
3x10-7M  continued  to  develop  normal  as  that  of  the  control  group  and  no
abnormalities were observed  48hpf (Table V).
By 144hpf embryos treated with 0.5x10-7M and 1x10-7M concentration of OA
exhibited no developmental abnormalities and continued normal development.
All of the embryos treated with 12x10-7M and 25x10-7M were coagulated. 60%
coagulation was observed among the zebrafish embryos treated with 6x10-7M and
no coagulated embryos exhibited developmental abnormalities, i.e. lack of
movement, severe yolk sac oedema, affected circulation, under developed fins and
affected eyes. Embryos treated with 2x10-7M and 3x10-7M showed some
developmental abnormalities, i.e. slight oedema and coagulation. In 3x10-7M
treated embryos observed developmental abnormalities were not significantly
different from the control embryos (Table V).
                                  A
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                                             B
Figure (A & B) 6x10-7M Ochratoxin A treated embryo after 144hpf.
Development of large yolk sac oedema.
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Table (V); Statistical analysed studied end point results for OTA by 48hfp and 144hpf
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching HR(mean)
Ochratoxin A 48hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 141.0
0.5x10-7M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 144.5
1x10-7M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 142.5
2x10-7M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 135.0
3x10-7M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 138.5
6x10-7M 0.0 1.0 1.5* 0.0 1.0 1.0 1.0 0.0 136.5
12x10-7M 0.0 1.0 2.5* 1.0* 1.0 1.0 1.0 0.0 130.0*
25x10-7M 0.0 1.0 3.0* 2.0* 1.0 1.0 2.0* 0.0 125.5*
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching Fins
Ochratoxin A 144hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
0.5x10-7M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
1x10-7M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
2x10-7M 0.5* 1.0 1.5* 1.5* 1.0 1.0 1.0 1.0 1.0
3x10-7M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
6x10-7M 1.0* 3.0* 3.0* 3.0* 1.5* 1.0 1.0 1.0 2.0*
12x10-7M 1.0* - - - - - - - -
25x10-7M 1.0* - - - - - - - -
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Sodium arsenate
Zebrafish embryos provide no evidence of phenotypic abnormal development
when cultured in sodium arsenate rearing media even as high as 16x10-3M
solution by 48hpf. After day six of sodium arsenate treatment all exposed embryos
developed normally as that of control group (Table VI).
               12x10-3M Sodium arsenate treated embryo after 144hpf. No
               developmental abnormalities, all studied parameters are normal
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Table (VI); Statistical analysed studied end point results for sodium arsenate by 48hfp and 144hpf
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching HR(mean)
Sodium arsenate 48hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 141.5
1.5x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 138.5
3x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 140.0
6x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 137.5
9x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 139.5
12x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 138.5
15x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 0.0 137.0
Concentration Time Coagulation Movement Circulation Oedema Eyes Tail Pigmentation Hatching Fins
Sodium arsenate 144hpf
Control 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
1.5x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
3x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
6x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
9x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
12x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
15x10-3M 0.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0
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LOEC and NOEC values table
Table (A) summary of the LOEC (lowest observed effect concentration) and
NOEC (no observed effect concentration) data after 48hpf and 144hpf for selected
endpoints.
NO* Not observed
Substance End point NOEC48hpf
(Molar)
LOEC48hpf
(Molar)
NOEC144hpf
(Molar)
LOEC144hpf
 (Molar)
Retinoic acid Coagulated eggs 10-7 NO 10-8 10-7.8
 Movement 10-7.4 10-7.6 10-8 10-7.8
 Circulation 10-7.8 10-7.6 10-7.8 10-7.6
 Extension of tail 10-7.6 10-7.4 10-7.8 10-7.6
 Oedema 10-8 10-7.8 10-8 10-7.8
 Heart rate 10-8 10-7.8 NO NO
 Eye 10-7.4 10-7.6 10-7.8 10-7.6
Lithium hydroxide  Coagulated eggs 16x10-2 NO 4x10-2 8x10-2
 Movement 16x10-2 NO 4x10-2 8x10-2
 Circulation 16x10-2 NO 4x10-2 8x10-2
 Extension  of tail 16x10-2 NO 8x10-2 12x10-2
 Oedema 16x10-2 NO 3x10-2 4x10-2
 Eyes 16x10-2 NO 8x10-2 12x10-2
Ethanol  Coagulated eggs 2% 2.5% 1% 1.25%
 Movement 1.75% 2% 1.5% 1.75%
 Circulation 1.25% 1.5% 1.25% 1.5%
 Extension  of tail 1.75% 2% 1.5% 1.75%
 Oedema 1% 1.25% 1% 1.25%
 Eyes 1.75% 2% 1.25% 1.5%
 Pigmentation 2% 2.5% 1.5% 1.75%
6-Amino
nicotinamide
 Coagulated eggs NO NO 1x10-6 3.5x10-6
 Movement 1x10-6 3.5x10-6 1x10-6 3.5x10-6
 Circulation 14x10-6 22x10-6 1x10-6 3.5x10-6
 Extension  of tail 22x10-6 29x10-6 1x10-6 3.5x10-6
 Oedema 1x10-6 3.5x10-6 1x10-6 3.5x10-6
 Eyes 3.5x10-6 7x10-6 1x10-6 3.5x10-6
 Hatching NO NO 7x10-6 14x10-6
Ochratoxin A  Coagulated eggs 25x10-7 NO 1x10-7 2x10-7
 Movement 25x10-7 NO 3x10-7 6x10-7
 Circulation 1x10-7 2x10-7 1x10-7 2x10-7
 Extension  of tail 25x10-7 NO 6x10-7 12x10-7
 Oedema 6x10-7 12x10-7 1x10-7 2x10-7
 Eyes 25x10-7 NO 3x10-7 6x10-7
 Pigmentation 12x10-7 25x10-7 6x10-7 NO
 Heart rate 3x10-7 6x10-7 NO NO
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Discussion
Identification of environmental agents that cause damage to unborn children is
absolutely imperative. Armed with the knowledge of those drugs, chemicals and
foodstuffs that human beings are routinely exposed to that are truly teratogenic,
exposures can be avoided, reduced or limited, and the incidence of tragic
teratogen-induced birth defects drastically lowered. The burden of this goal
currently rests heavily upon animal-based testing, but none of the animal model
fulfilling the ideal teratology animal model criteria such as producing large litters
after a short gestation, inexpensive maintenance, and an inability and
unwillingness to ‘bite, scratch, kick, howl or squeal’ (Wilson, 1975), and also due
to some ethically limitations it is not possible to perform extensive teratological
testing on routine basis. Thus, a need exists for assays that retain the high value
of in vivo toxicity testing, but can be rapidly performed on a large number of
chemicals. Since the thalidomide catastrophe scientists are exploring new
alternative for teratological testing (McBride 1961; Lenz 1966). In the recent
times zebrafish emerge as a competitive laboratory animal model. In the present
study zebrafish embryos were used to test the teratogenicity of some potential
human teratogens. Chemicals with known potential teratogenicity to human were
selected from different categories of chemicals to study the potential of zebrafish
model for teratological studies. Comparisons of the results were done with other
laboratory animal species as shown in the Table (B).
Species                                                          Substances
Retinoic
acid
Lithium
hydroxide
Ochratoxin
A
Ethanol 6-Amino
 nicotinamide
Arsenic
oxide
+/+-/- +%
Mouse + +- + + + + 5/1/0 83%
Rat + +- + + + + 5/1/0 83%
Rabbit + - + + + 4/0/1 80%
Hamster + + + + 4/0/0 100%
Primate + - + +- 2/1/1 50%
Pig +- + + 2/1/0 50%
Zebrafish + + + + + - 5/0/1 83%
Table (B)
“+” positive teratogenic results
“-” negative teratogenic results
“+-”unknown teratogenic results
Retinoic acid is expressed in a gradient along the anterior-posterior axis of the
zebrafish. Different Hox genes are expressed along the anterior-posterior axis
according to the concentration of RA present in that region, embryos showed
truncation at anterior and posterior axis as shown in the results because this
exogenous retinoic acid altered the natural gradient, causing ectopic expression of
Hox genes. Regions that would normally have a lower concentration of retinoic
acid now had a higher concentration and hence expressed genes similar to those
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expressed in the hindbrain and trunk region of the embryo, where the largest
concentration of retinoic acid is usually found. The magnitude of the effects of
treatment with exogenous retinoic acid appeared to be concentration dependent
Embryos showed lack of movement, lower heart rate, microphthalmia to
anophthalmia, short tail and yolk sac oedema which may be indicative of their
stunted growth and a less that normal level of metabolization of the yolk sac
nutrients. The developmental abnormalities caused by RA among the zebrafish
embryos were very much obvious at early stages (48hpf) and later stages (144hpf)
of development on the anterior (craniofacial) and posterior (tail) trunk. The
phenotypic developmental abnormalities of anterior and posterior trunk of the
zebrafish embryos are similar to those observed in human i.e. defective ears,
absent or small jaws, cleft palate, aortic arch abnormalities and abnormalities of
the central nervous system, and in mice i.e. axial truncation, reduction in the size
of first and second pharyngeal arches which normally form the jaws, ears and
other facial bones (Gilbert, 2003; Ligas, 2000; Koren G, 1994). Abnormalities of
the CNS in the zebrafish embryos can be correlated to the rapid or reduced
movement of the embryos (Behra et al., 2004; Bretaud et al., 2004; Granato et al.,
1996; Lam et al., 2005; Mckinley et al., 2005; Tiedeken et al., 2005). In the
present discussion comparison of the anterior trunk abnormalities of the zebrafish
embryos are made with the phenotypic craniofacial abnormalities of the other lab
animal models, coagulation with low birth rate, still birth and high infant
mortality and in general anterior and posterior trunk malformations with stunted
growth of the new born.
Lithium hydroxide treatment affected the anterior-posterior morphogenesis of
zebrafish embryos such that higher concentrations of this substance lead to
increasingly greater inhibition of anterior and posterior development. Lithium-
induced teratogenesis has been shown to perturb the development of ventral
structures in premidblastular zebrafish, when the blastula is still forming
morphogenetic gradients of proteins in the Wnt signalling pathway (such as b-
catenin) and continuing to transcribe maternal mRNAs. In these early embryos,
lithium teratogenesis leads to the expression of bustled and radialized phenotypes,
which exhibit hyperdorsalization (Stachel et al., 1993). In the sphere-stage
embryos, morphogenetic gradients have already been established, so the effect of
lithium in this case probably occurs downstream of these events. The phenotype
of LiOH cultured embryos higher then 3x10-2M exhibited severe yolk sac oedema,
microphthalmia, short tail, scoliosis, under developed fins and lack of movement.
Embryos cultured in 8x10-2M and higher concentration of LiOH showed high
mortality. Similar developmental malformations induced by lithium are observed
in other vertebrate species e.g. in mice i.e. reduction in the number of new born
,vertebral defects, cleft palate, craniofacial abnormalities (Chenroff and
Kavloc,1982; Szabo,1970; Smithberg and Dixit,1982; RTECS,1995a), in rat i.e.
malformations of eyes, external ears, cleft palate, reduction in the number of live
birth(Wright et al., 1970; Marathe and Thomas,1986), in pig i.e. reduction in the
live piglets numbers, still birth and high mortality among the live piglets(Kelley
et al., 1978), and in human i.e. Ebstein’s anomaly ; a congenital cardiac
abnormality, still birth and other developmental defects in the Apgar Score (The
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Apgar  score  is  a  standardised  way  of  checking  the  health  of  a  newborn  baby)
“Appearance, Pulse, Grimace, Activity, Respiration” (RTECS, 1995b).
Blader and Strähle (1998) have studied that embryonic development of zebrafish
is affected by ethanol in a manner similar to higher vertebrates. Phenotypic
abnormalities caused by ethanol were observed among the zebrafish embryos
cultured higher than 1% ethanol solution as shown in the Table (A) by LOEC and
NOEC values. The effected range of ethanol in the present study is significantly
different with Blader and Strähle´s (1998) ethanol concentration 2.4 percent.
There was high mortality rate among the zebrafish embryos cultured higher then
1.5% and this is may be due to apoptosis by activating the cell’s self destruction
machineries as suggested by Sulik et al. (1988). Microphthalmia and
anophthalmia was observed in embryos treated with 2% and 2.5% ethanol,
supporting the fact that ethanol does affect eyes development among zebrafish
embryos (Blader and Strähle, 1998). Ethanol did cause defective development in
the posterior structures in zebrafish embryos. Although the mechanisms behind
the observed deformities of the trunk and the tail are not known, it can be
conjectured that the impairment of epiboly may be responsible. Blader and
Strähle (1998) noted that epiboly was marginally impaired by the treatment, with
the advance of the blastoderm margin lagging behind untreated controls by 10 to
15% toward the end of gastrulation. Epiboly establishes the posterior area of the
embryo including the trunk region and the tail bud and, therefore, it seems
reasonable that impairing the last 10-15% of epiboly may cause defective trunk
and tail (Gilbert, 2003). Lack of pigmentation was observed among some the
embryos treated with higher concentration of ethanol. The mechanism for this
lack of pigmentation is not known but it is thought that ethanol might cause
deformities in the spinal cord from which neural crest cells destined to become
melanocytes arise (Gilbert, 2003). These observed developmental abnormalities
are similar with abnormalities observed in human, chicken and rat i.e. metal
retardation, behavioural abnormalities, craniofacial malformation, heart and
neural crest defects (Gilbert, 1997; Cartwright et al., 1995; Smith, 1997; Sulik et
al., 1988; Koren G, 1994).
6-AN 3.5x10-6M rearing solution and higher concentrations caused high
mortality, low hatching rate, lack of movement, affected circulation,
microphthalmia, short to no developed fins and short tail. It can be conjectured
that 6-AN inhibition of nicotinamide adenine dinucleotide dependent reactions
during ATP synthesis is responsible for these malformations. When 6-AN
decreases the pentose pathway then the arterioles partially lose their ability to
regulate the blood flow and blood resistance increases then all the normal
mechanisms and metabolisms of the body effected and this may in turn produce
malformations in the developing embryos (Wilson et al., 1975; Dietrich et al.,
1958). This malformations pattern is similar with that observed in mice i.e.
decrease litter size, CNS problems (Matschke et al., 1997), cleft palate, hind limb
defects (Pinsky et al., 1960), in rat i.e., stunted growth, foetal death, craniofacial
abnormalities, CNS problems (TJADAB, 1975), in rabbit i.e. stunted growth,
cardio vascular problems, CNS problems and craniofacial including eyes and ears
defects (TJADAB, 1983).
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Zebrafish embryos cultured higher then 1x10-7 rearing media of OA develop
malformations. By day six these embryos presented high mortality and affected
circulation and spontaneous movement, yolk sac oedema, microphthalmia and
under developed fins. These malformations may be due to chromosomal
aberrations because it can cause cell death, retardation of differentiation in
developing embryos (Wilson, 1973; Manolova et al., 1990). Another possible way
of explanation for these malformations is OA-DNA adducts in the zebrafish
embryos body tissues (Pfohl-Leszkowicz et al., 1991, 1993; Grosse et al., 1995,
1997; Castegnaro et al., 1998; Pfohl-Leszkowicz et al., 1998).  These observed
malformation pattern is similar with that observed in rat i.e. high mortality,
decrease in the number of new born, decrease foetal weight, celosome with
oedema and CNS abnormalities (More´ and Galtier, 1974; Kinhara et al., 1984),
and in Mice i.e. high mortality craniofacial malformation, microphthalmia,
anophthalmia, malformed tail and limbs (Singh and Hood, 1985; Arora et
al.,1981).
No arsenic related mortalities or deformities were observed in any of the
treatments performed. There were no notable mortalities or deformations were
observed at any experimental concentrations among the zebrafish embryos at
48hpf and 144hpf. These results are opposing to the other lab animal results
because arsenic is a proven teratogenic substance as studies have shown that
arsenic can cross the mammalian placenta, affecting developing embryos whose
mothers undergo exposure (Wlodarczyk et al., 1996). One possible reason for the
arsenic’s apparent lack of effect on zebrafish development is that neural
patterning defects in vertebrates, such as those associated with arsenic exposure,
are notoriously difficult to detect from morphological observation alone
(Furutani-Seiki et al., 1996). The neural tube forms by the process of apoptotic
cavitations in fish, as compared to neural groove invagination in mammals, and
as a result, makes gross morphological observation of neural tube defects much
harder to recognize. Arsenic exists in trivalent and pentavalent ionic forms, and
is often given as either sodium arsenate (As(V)) or arsenic trioxide (As(III)), with
sometimes opposing results. Some studies have suggested that As(V) is less toxic
to fish than As(III), an identical result to findings in higher vertebrates
(Dabrowski 1975). This may explain the absence of abnormalities as in this study
As(V) was used for the experiment. But this also opposes the phenomena that
only the trivalent ion of arsenic has direct biological ramifications: As(V) must be
converted to As(III) to be active (Peterková and Puzanová 1974). Kalter (1968)
noted that the effect of teratogens in organisms such as fish and amphibians is
primarily dependent upon the stage at which the embryo is exposed to the
chemical. Response to arsenic is also species dependent and therefore cannot be
generalized based on broader classifications.
Results and the above discussion show that the zebrafish embryo toxicity test has
provided positive evidences about the teratogens testing. This test is simple to
handle, easy to understand, economical and easily repeatable. In the present study
the percentage of positive results is high (83%) as shown in the Table (B) and
comparable to other laboratory animal species. But there are a lot of advantages
with this animal model, i.e. this specie is easily obtainable, inexpensive, has high
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fecundity, a small size (3 to 5cm), short generation time, rapid development,
external fertilization, translucent embryos and is easy to maintain at laboratory
level (Laale, 1977). Under appropriate conditions one female lays approximately
50 to 200 eggs per day (Laale, 1977), so the sample size can be large enough as
desirable. The zebrafish comes close to being the ideal model organism for
vertebrate developmental studies because it appears to combine the best features
of all the other models. Like most of the amphibians, zebrafish embryos develop
externally and can be viewed and manipulated at all stages. However, zebrafish
development is more rapid than most of the amphibians and the organization of
the embryo are simpler and (like worms and fruit flies) the embryo is transparent.
Like the mouse, the zebrafish is amenable to genetic analysis and has a similar
generation interval (2-3 months). However, zebrafish are smaller than mice and
they produce more offspring in a shorter time. A female zebrafish can lay up to
200 eggs per day, while a mouse may produce a litter of up to 15 embryos in 21
days.
 Most of the proof-of-concept studies performed so far have shown that known
teratogens (e.g. Valproic acid, cadmium and tetrachlorodibenzo-para-dioxin etc)
in humans can be recapitulated in the zebrafish (Rubinstein, 2006). It still
remains to be proved, however, whether drugs with unknown toxicity
characteristics will cause effects in zebrafish embryos. Studies with wider range
of compounds with unknown toxicity characteristics will allow toxicologists to
predict with reasonable assurance that such effects are likely in humans.
Furthermore, it may be difficult to correlate the concentration and absorption of
these compounds by zebrafish embryos in the media required to cause toxic
effects in zebrafish to the plasma concentration of compound that would cause the
same effect in humans. Determination of the actual amount of compound
absorbed by zebrafish as well as an understanding of compound metabolism in
zebrafish will be important to make useful correlations. Potential differences in
the physiology of embryos should also be considered. Based on the results of this
preliminary study, it can be said that in future with more extensive research and
with wider range of compounds zebrafish assay can be integrated into
teratological and drug toxicity screening programmes on a commercial level for
the drugs and chemicals before human use. This work has been a necessary first
step toward developing zebrafish as a model to predict toxicity of compounds in
humans.
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